View in EDS PDF Full Text

Myostatin as a fibroblast‐activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Myostatin as a fibroblast‐activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma.
Authors: Yoshio, Sachiyo1 (AUTHOR) sachiyo@hospk.ncgm.go.jp, Shimagaki, Tomonari1,2 (AUTHOR), Hashida, Ryuki3 (AUTHOR), Kawaguchi, Takumi4 (AUTHOR), Tsutsui, Yuriko1 (AUTHOR), Sakamoto, Yuzuru1 (AUTHOR), Yoshida, Yuichi1 (AUTHOR), Kawai, Hironari1 (AUTHOR), Yoshikawa, Shiori1 (AUTHOR), Yamazoe, Taiji1 (AUTHOR), Mori, Taizo1 (AUTHOR), Osawa, Yosuke1 (AUTHOR), Itoh, Shinji2 (AUTHOR), Fukai, Moto5 (AUTHOR), Yoshizumi, Tomoharu2 (AUTHOR), Taketomi, Akinobu5 (AUTHOR), Mori, Masaki2 (AUTHOR), Kanto, Tatsuya1 (AUTHOR) kantot@hospk.ncgm.go.jp
Source: Hepatology Research. Jul2021, Vol. 51 Issue 7, p803-812. 10p.
Database: Academic Search Ultimate
Description
ISSN:13866346
DOI:10.1111/hepr.13667